Dear Stoner: I’m a chronic-pain patient in a state that hasn’t legalized marijuana. I’ve been prescribed opioids for years, which has led to depression and anxiety issues. Is there any way for me to mail-order THC and CBD edibles from a legalized state?
Casara Andre is stuck between a rock and a hard place. In fact, so are all of her clients and some of her colleagues. The owner of Scheduled Relief veterinary clinic and a practicing veterinarian, Andre thinks cannabis products have medical benefits for pets, but she can’t legally recommend cannabis for her furry patients, and there’s little published research on the benefits of cannabis for animals to support her beliefs.
Colorado is known for majestic mountains, craft breweries and, of course, its wonderful world of weed. However, not everyone knows to take advantage of the state’s most progressive medicinal plant-based resource: cannabidiol, or CBD.
On July 20, the Senate Appropriations Committee approved the Energy and Water Development appropriations bill for fiscal year 2018, authorizing $38.4 billion in spending. Wedged into this bill was the Industrial Hemp Water Rights Act, a piece of bipartisan legislation introduced in part by Colorado senators Michael Bennet and Cory Gardner.
Days after a letter from Attorney General Jeff Sessions surfaced, asking congressional leaders to revoke federal protections for medical marijuana, senators have introduced a bill that would protect medical marijuana patients in states where it’s legal while also removing cannabidiol (CBD) from the Controlled Substances Act and expanding research on marijuana.
Senators Cory Booker (D-New Jersey), Mike Lee (R-Utah), Kirsten Gillibrand (D-New York), Rand Paul (R-Kentucky), Al Franken (D-Minnesota) and Lisa Murkowski (R-Arkansas) introduced the Compassionate Access Research and Respect the States (CARERS) Act on June 15. The bill would protect medical marijuana users from federal prosecution, allow Department of Veterans Affairs doctors to recommend medical marijuana to veterans, and loosen multiple restrictions on cannabis research and medical compounds.